Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Arrowhead Pharma (ARWR)

44.915   0.605 (1.37%) 09-27 22:18
Open: 43.98 Pre. Close: 44.31
High: 45.07 Low: 43.65
Volume: 847,541 Market Cap: 4,594M
Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Pasadena, California and currently employs 134 full-time employees. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company's therapies trigger the RNA interference mechanism to induce knockdown of target genes. The firm is focused on developing drugs for diseases with a genetic basis, characterized by the overproduction of one or more proteins. The firm's preclinical pipeline of RNA interference (RNAi) therapeutics includes both subcutaneously administered liver-targeted candidates and extra-hepatic candidates. The firm's pre-clinical-stage drug candidates include ARO-HBV, ARO-AAT, ARO-LPA, ARO-AMG1, ARO-F12 and ARO-HIF2. ARO-HBV is an RNAi therapeutic candidate for the treatment of chronic hepatitis B infection. ARO-AAT is a therapeutic candidate for the treatment of liver disease associated with Alpha-1 Antitrypsin Deficiency.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 45.103 - 45.317 45.317 - 45.518
Low: 43.104 - 43.35 43.35 - 43.58
Close: 44.514 - 44.903 44.903 - 45.267

Technical analysis

as of: 2020-09-25 4:27:28 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 62.04     One year: 72.47
Support: Support1: 40.60    Support2: 32.86
Resistance: Resistance1: 53.12    Resistance2: 62.04
Pivot: 39.97
Moving Average: MA(5): 43.88     MA(20): 39.98
MA(100): 40.34     MA(250): 42.13
MACD: MACD(12,26): 0.79     Signal(9): -0.14
Stochastic oscillator: %K(14,3): 58.05     %D(3): 55.40
RSI: RSI(14): 57.75
52-week: High: 73.72  Low: 19.51  Change(%): 59.4
Average Vol(K): 3-Month: 143901  10-Days: 393134

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ARWR has closed below upper band by 25.2%. Bollinger Bands are 116.3% wider than normal. The large width of the bands suggest high volatility as compared to ARWR's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Thu, 24 Sep 2020
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) - Business Wire

Wed, 23 Sep 2020
Should You Buy Arrowhead Pharmaceuticals Inc (ARWR) Stock? - InvestorsObserver

Wed, 16 Sep 2020
Arrowhead Pharmaceuticals, Myomo leads healthcare gainers, Novus Therapeutics, Jounce Therapeutics among major losers - Seeking Alpha

Wed, 16 Sep 2020
Looking Into Arrowhead Pharmaceuticals's Return On Capital Employed - Benzinga

Wed, 16 Sep 2020
Why Arrowhead Pharmaceuticals Stock Is Soaring Today - The Motley Fool

Sun, 13 Sep 2020
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shareholders Have Enjoyed A Whopping 906% Share Price Gain - Simply Wall St

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 102
Shares Float (M) 100
% Held by Insiders 2.76
% Held by Institutions 63.91
Shares Short (K) 9,420
Shares Short P. Month (K) 9,830

Stock Financials

EPS -0.250
EPS Est This Year -0.420
EPS Est Next Year -0.660
Book Value (p.s.) 4.820
Profit Margin -19.75
Operating Margin -27.01
Return on Assets (ttm) -4.7
Return on Equity (ttm) -6.8
Qtrly Rev. Growth -35.9
Gross Profit (p.s.) 1.650
Sales Per Share 1.209
EBITDA (p.s.) -0.275
Qtrly Earnings Growth
Operating Cash Flow (M) -71
Levered Free Cash Flow (M) -67

Stock Valuations

PE Ratio -179.66
PEG Ratio
Price to Book value 9.32
Price to Sales 37.16
Price to Cash Flow -64.96

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.